These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7796571)

  • 21. A 56-year-old woman with COPD and multiple pulmonary nodules.
    Sakkour A; Wang T; Tashkin D
    Chest; 2008 Feb; 133(2):566-9. PubMed ID: 18252924
    [No Abstract]   [Full Text] [Related]  

  • 22. [Allergic bronchopulmonary aspergillosis successfully treated with itraconazole].
    Matsuzaki Y; Jimi T; Tao Y; Takada S; Miyazaki N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):352-6. PubMed ID: 9168655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of pulmonary aspergilloma.
    Judson MA; Stevens DA
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1375-7. PubMed ID: 11890350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Havette A; Regard L; Roche N; Burgel PR
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34887327
    [No Abstract]   [Full Text] [Related]  

  • 25. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis.
    Mannes GP; van der Heide S; van Aalderen WM; Gerritsen J
    Lancet; 1993 Feb; 341(8843):492. PubMed ID: 8094509
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply: Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Agarwal R; Muthu V
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34887329
    [No Abstract]   [Full Text] [Related]  

  • 27. Tremor: a newly described adverse event with long-term itraconazole therapy.
    Lestner JM; Denning DW
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):327-9. PubMed ID: 20185472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
    Salcedo Posadas A
    Enferm Infecc Microbiol Clin; 2000; 18(6):301-3. PubMed ID: 11075497
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy.
    Caras WE; Pluss JL
    Mayo Clin Proc; 1996 Jan; 71(1):25-30. PubMed ID: 8538227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic necrotizing pulmonary aspergillosis complicated by pneumothorax.
    Thurnheer R; Moll C; Röthlin M; Krause M
    Infection; 2004 Aug; 32(4):239-41. PubMed ID: 15293081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA.
    Godet C; Meurice JC; Roblot F; Kauffmann-Lacroix C; Verdaguer M; Frat JP; Cadranel J
    Eur Respir J; 2012 May; 39(5):1261-3. PubMed ID: 22547734
    [No Abstract]   [Full Text] [Related]  

  • 32. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
    N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cushing's syndrome without excess cortisol.
    Woods DR; Arun CS; Corris PA; Perros P
    BMJ; 2006 Feb; 332(7539):469-70. PubMed ID: 16497762
    [No Abstract]   [Full Text] [Related]  

  • 34. Three cases of pulmonary sarcoidosis associated with aspergilloma.
    Varpela E; Mattson K; Kahanpää A; Laitinen LA
    Ann Clin Res; 1978 Dec; 10(6):313-7. PubMed ID: 742830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungals in the treatment of allergic bronchopulmonary aspergillosis.
    Leon EE; Craig TJ
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):511-6; quiz 516-9. PubMed ID: 10400477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring.
    Lestner JM; Roberts SA; Moore CB; Howard SJ; Denning DW; Hope WW
    Clin Infect Dis; 2009 Sep; 49(6):928-30. PubMed ID: 19681707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe asthma with fungal sensitization in a child: response to itraconazole therapy.
    Vicencio AG; Muzumdar H; Tsirilakis K; Kessel A; Nandalike K; Goldman DL
    Pediatrics; 2010 May; 125(5):e1255-8. PubMed ID: 20385639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant.
    Pirro E; De Francia S; Banaudi E; Riggi C; De Martino F; Piccione FM; Giustetto C; Racca S; Agnoletti G; Di Carlo F
    Br J Clin Pharmacol; 2011 Dec; 72(6):982-4. PubMed ID: 21707701
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic necrotizing pulmonary aspergillosis successfully diagnosed, treated, and followed by ultrathin bronchoscope.
    Nakamura Y; Shirai M; Hayakawa H; Nakano Y; Fujita K; Suda T; Chida K
    Mycoses; 2008 Jan; 51(1):86-8. PubMed ID: 18076604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Kaffarnik M; Utzolino S; Blaich A; Hopt UT
    Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.